Navigation Links
Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
Date:7/29/2009

PALO ALTO, Calif., July 29 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today at the 6th Annual Meeting of the Society of NeuroInterventional Surgery (www.snisonline.org) that Nfocus has earned a European CE Mark approval for its novel guiding catheter, the Echo(TM) Distal Access Catheter.

"The Echo's unique construction gives it the ability to enable endovascular procedures in very far-reaching vessel locations -- yet provide a stable platform for placing today's most advanced interventional devices," noted President and CEO Martin S. Dieck.

"The European CE Mark approval gives Nfocus the ability to enter the top end of the interventional guiding catheter market with our new Echo catheter. Endovascular surgeons and interventional neuroradiologists will appreciate the extreme suppleness of the distal end and the exceptional support of the proximal section -- both produced by the key uni-body construction."

The Echo(TM) Distal Access Catheter has been cleared in Europe to provide support and vessel access in peripheral, coronary and neurovascular interventional and diagnostic procedures. In today's advanced and complex endovascular procedures, a high-quality guiding catheter is required to allow operative devices or implants to reach the target vessel. It is critical for the guiding catheter to be atraumatic and flexible within the distant and smaller target vessel -- yet provide stable and firm support in the larger vessels where the device enters the body.

"Nfocus recognized a key market opportunity and has applied its unique design and development talents to produce the Echo," continued Mr. Dieck. "Echo will help enable many advanced endovascular procedures."

About Nfocus Neuromedical Inc.

Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier venture investors, the Company is developing revolutionary systems to treat neurovascular disease, including brain aneurysms, that are simple, safe, cost-effective and curative.

Nfocus was incubated at In-Cube Labs and is backed by Oxford Bioscience Partners, Technology Partners and DFJ-ePlanet Ventures.

To learn more about the Nfocus Neuromedical development programs focused on providing faster, simpler and more permanent treatment of vascular diseases of the brain and spine, please visit the new Nfocus website at: www.nfocusneuro.com.

For more information about aneurysms and hemorrhagic stroke see: www.strokeassociation.org and www.snisonline.org


'/>"/>
SOURCE Nfocus Neuromedical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
2. Nfocus Neuromedical Announces Acquisition of StarFire Medical
3. Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board
4. National Healthcare Providers Select onFocus epm(TM) To Help Ensure Success on Financial and Strategic Objectives
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Bill ... 2017 collaboration with the American Heart Association; “Howe” Healthy is Your Heart Drawing ... stay healthy and active. Each year, Bill Howe Plumbing, Heating & Air receives over ...
(Date:1/19/2017)... MD (PRWEB) , ... January 19, 2017 , ... Sales ... six new clients into the US market. , Over the past 20 years SFI ... past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Breast Surgery Symposium, a conference where hundreds of surgeons from over fifteen different ... Covering topics from cosmetic breast augmentation to breast reconstruction for breast ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting of a new ... the benefits of fidgeting to relieve stress and anxiety. No one was more ... Ink Pen had just completed a successful Kickstarter campaign raising $67,000 on the popular ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually learn facts and ... OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are common conditions that ... infographic to explain the seven types of hyperhidrosis. This visual creates awareness about ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: